Zvi Bar
Long only, value, special situations, long-term horizon

Stereotaxis Should Soon Attract Investors Or A Buyer

Though still a highly speculative equity, Stereotaxis (NASDAQ:STXS) appears to be in a sweet spot for potential revenue growth and for becoming an acquisition target by larger companies that are in the fields of medical devices and/or robotics. Shares of STXS have had a volatile last several months, but have recently performed well and appear poised to continue doing so throughout 2014. See a recent performance chart (click to enlarge):

Stereotaxis is the market leader in robotic navigation solutions for the treatment of arrhythmias and coronary disease, with a portfolio of over 100 patents for use in hospital surgical suites. The company's key device uses magnets to generate a Tesla field in a patient's heart, and then uses...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details